const [flowchartData, setFlowchartData] = useState([
    {
        "id": "1",
        "name": "Suspect / Confirmed Case",
        "color": "#d6958e",
        "border": "#d6958e",
        "featured_text": null,
        "content": "<div>\r\n<p><strong>Lorem Ipsum</strong> is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</ p >\r\n </div><div>\r\n<p><strong>Lorem Ipsum</strong> is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</ p >\r\n </div><div>\r\n<p><strong>Lorem Ipsum</strong> is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</ p >\r\n </div>",
        "type": "rounded",
        "parentId": "",
    },
    {
        "id": "2",
        "name": "Very Mild",
        "color": "#ce9e2f",
        "border": "#ce9e2f",
        "featured_text": "Generally  Asymptomatic",
        "content": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Home isolation is recommended for very mild/ presymptomatic/ asymptomatic patients, provided they fulfill certain criteria.</span></span></span></p>",
        "type": "diamond",
        "parentId": "1"
    },
    {
        "id": "3",
        "name": "Mild",
        "color": "#ce9e2f",
        "border": "#ce9e2f",
        "featured_text": "RR < 24/ min SpO2 > 94%",
        "content": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Mild illness is characterized by </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"><strong>fever and/ or uncomplicated URTI</strong></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">.</span></span></span><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">There is no dyspnea or hypoxemia in these patients.</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Findings:</span></span></span></p><ul><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Respiratory rate &lt; 24 / min.</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">SpO2 (room air) &gt; 94%</span></span></span><br />&nbsp;</li></ul><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Admit the patient to a COVID care centre,&nbsp; First Referral Unit (FRU), Community Health Centre (CHC), sub-district, and district hospitals.</span></span></span></p>",
        "type": "diamond",
        "parentId": "1",
    },
    {
        "id": "4",
        "name": "Moderate illness",
        "color": "#ce9e2f",
        "border": "#ce9e2f",
        "featured_text": "RR ≥ 24/ min SpO2 < 94%",
        "content": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Moderate illness is characterized by </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"><strong>pneumonia with no signs of severe disease</strong></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">.</span></span></span></p><p><strong><u><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Findings</span></span></span></u></strong><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Respiratory rate &ge; 24 / min</span></span></span></p><p style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">SpO2 (room air) &lt; 94%&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Admit the patient to a Dedicated COVID health centre, district hospital, or medical college hospitals.</span></span></span></p><p></p>",
        "type": "diamond",
        "parentId": "1",
    },
    {
        "id": "5",
        "name": "Severe illness",
        "color": "#ce9e2f",
        "border": "#ce9e2f",
        "featured_text": "RR ≥ 30/ min SpO2 < 90%",
        "content": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Severe illness is characterised by </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"><strong>respiratory distress requiring mechanical ventilation</strong></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">. (non-invasive &amp; invasive)</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Findings:</span></span></span></p><ul><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Respiratory rate &ge; 30 / min.</span></span></span></li></ul><ul><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">SpO2 (room air) &lt; 90%&nbsp;</span></span></span></li></ul><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Admit the patient to a Dedicated COVID Hospital.</span></span></span></p><p></p><p></p>",
        "type": "diamond",
        "parentId": "1",
    },
    {
        "id": "6",
        "name": "Home isolation",
        "sort": 1,
        "color": "#74c5d8",
        "border": "#74c5d8",
        "featured_text": "",
        "content": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Applicable only for very mild/ asymptomatic cases. The patient should fulfill certain criteria in order to follow home isolation.</span></span></span></p><p></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Criteria:</span></span></span></p><p></p><ol><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">The house should have adequate facilities for self-isolation as well as quarantine of family members.&nbsp;</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Immunocompromised individuals are not eligible.</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">The elderly and those with co-morbidities should first be evaluated by the doctor before allowing home isolation.&nbsp;</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">24/7 availability of a caregiver, who should also communicate with the hospital.&nbsp;</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">HCQ prophylaxis for the caregiver and other close contacts.&nbsp;</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">The patient should download Arogya Setu app which should be active at all times.&nbsp;</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">The patient should monitor his condition regularly and provide updates to the surveillance team.&nbsp;</span></span></span></li></ol><p><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Further requirements in terms of personal hygiene and waste disposal should also be met before the individual is allowed to self-isolate. </span></span></span><br /><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Further details can be found here : </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#1155cc\"><u>Home isolation guidelines</u></span></span></span></p>",
        "type": "rectangle",
        "parentId": "2"
    },
    {
        "id": "7",
        "name": "Admit to CCC",
        "color": "#74c5d8",
        "border": "#74c5d8",
        "featured_text": "",
        "content": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">This is done in mild cases.</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Precautions to be taken:</span></span></span></p><ul><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Contact and droplet precautions</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Hand hygiene</span></span></span></li></ul><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Hydration</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Hydration and symptomatic management is the mainstay of treatment for mild cases.</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Fever is treated using Paracetamol, and cough by antitussives.</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Hydroxychloroquine</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Given in high risk cases like:</span></span></span></p><ol><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Age &ge; 60 years</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Hypertension, Diabetes, or other immunocompromised states</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Cerebrovascular disease</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Obesity (BMI&nbsp; &ge; 25)</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Chronic lung / kidney / liver disease</span></span></span></li></ol><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Dosage: </span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tab. HCQ</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"><strong> 400 mg BD </strong></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">for 1 day followed by </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"><strong>400 mg OD</strong></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"> for 4 days.</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Avoid HCQ in patients with underlying cardiac disease, unexplained syncope, or QT prolongation.</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"><span style=\"background-color:#fff2cc\"><strong>/* make into illustration */</strong></span></span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Refer to a higher centre</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Refer when Respiratory rate &ge; 24 </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"><strong>OR </strong></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">SpO2 (room air) &lt;94%</span></span></span></p><p></p>",
        "type": "rectangle",
        "parentId": "3"
    },
    {
        "id": "8",
        "name": "Admit to DCHC",
        "color": "#74c5d8",
        "border": "#74c5d8",
        "featured_text": "",
        "content": "<p><span style=\"display:none\">&nbsp;</span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Moderate cases are admitted to the DCHC. The treatment protocol includes 4 standard and 2 investigational therapies.&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Standard therapies are:</span></span></span></p><ol><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Oxygen support</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Anticoagulation</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Corticosteroids</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Antivirals</span></span></span></li></ol><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">New therapies (investigational) include: </span></span></span><br />&nbsp;</p><ol><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Remdesivir</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Convalescent plasma</span></span></span></li></ol><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Oxygen support&nbsp;</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Target SpO2: 92-96% (88-92% in patients of COPD)</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Preferred method of O2 support: Non-rebreathing facemask. If HFNC or simple nasal cannula is used, then an N95 mask should be placed over it, because of aerosolisation.&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Awake proning can be used in patients who are hypoxemic even with an O2 flow of&nbsp; &gt; 4L/min, if it&rsquo;s not contraindicated.&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Contraindications:</span></span></span></p><ol><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Hemodynamic instability&nbsp;</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Close monitoring not possible</span></span></span></li></ol><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">&nbsp;If proning is done, then there should be a positional change every 30 - 120 mins, from prone to lateral decubitus and sitting upright positions.&nbsp;</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Anticoagulation</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">A prophylactic dose of LMWH / UFH should be given, if not contraindicated.&nbsp;&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">E.g. Enoxaparin 40 mg s.c daily.&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Contraindications: End stage renal disease, active bleeding, emergency surgery</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Use a validated score to assess bleeding risk (HAS-BLED score). D-Dimer and SIC score can be used for further risk stratification. SIC score &ge; 4 implies a greater risk of bleeding. </span></span></span><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">If the patient is currently taking anti-platelet medication, follow AHA / ESC or ISTH guidelines.</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Corticosteroids</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Steroids are given for 3 - 5 days. Either Methylprednisolone IV or Dexamethasone is used.</span></span></span><br /><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Dosage:</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Methylprednisolone 0.5 - 1 mg/kg IV&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Dexamethasone 0.1 - 0.2 mg/kg</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Antivirals</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tab. HCQ is given only after the following assessment is made: </span></span></span><br />&nbsp;</p><ul><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">CBC with differential count, Absolute lymphocyte count, RFT/LFT every 24 hours.</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">ECG assessment for QT interval, CRP, D-Dimer and Ferritin levels every 48 - 72 hours.</span></span></span><br />&nbsp;</li></ul><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Dosage:</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tab. HCQ<strong> 400 mg BD </strong>for 1 day followed by <strong>400 mg OD</strong> for 4 days.</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Remdesivir</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Remdesivir is an investigational therapy that&rsquo;s given only after informed and shared decision making in moderate to severely ill patients who are on oxygen or mechanical ventilation (preferably early in the disease).&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Remdesivir is a broad-spectrum antiviral.</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Dosage:</span></span></span><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Inj. Remdesivir </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"><strong>200 mg IV</strong> for 1 day followed by <strong>100 mg IV</strong> for 4 days.</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Contraindications:&nbsp;</span></span></span></p><ul><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">AST/ALT &gt; 5 times upper limit of normal&nbsp;</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Severe renal impairment&nbsp;</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Pregnancy or lactating females&nbsp;&nbsp;</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Children (&lt; 12 years of age)</span></span></span></li></ul><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Convalescent plasma</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Convalescent plasma therapy is given only after informed and shared decision making in moderate to severely ill patients with persistent or increasing oxygen requirement.</span></span></span></p><p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Dosage:&nbsp;</span></span></span></strong></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">200 ml of convalescent plasma as a single dose, repeat after 24 hours if needed.&nbsp;</span></span></span></p><p><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Refer to higher centre</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Monitor for&nbsp;</span></span></span></p><ol><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Increased work of breathing (use of accessory muscles)</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Hemodynamic instability</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Increased oxygen requirement</span></span></span></li></ol><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">If any of these are noticed, refer the patient to a Dedicated COVID hospital.</span></span></span></p><p></p><p><span style=\"display:none\">&nbsp;</span></p><p></p>",
        "type": "rectangle",
        "parentId": "4"
    },
    {
        "id": "9",
        "name": "Admit to DCH",
        "color": "#74c5d8",
        "border": "#74c5d8",
        "featured_text": "",
        "content": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Severe cases are admitted to the DCH. The treatment protocol includes 3 standard and 1 investigational therapy.</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Standard therapies are:&nbsp;</span></span></span></p><ol><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Oxygenation</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Anticoagulation</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Corticosteroids</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Sedation and Nutrition&nbsp;</span></span></span></li></ol><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">New therapies (investigational) include:</span></span></span></p><ol><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tocilizumab</span></span></span></li></ol><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">For the management of sepsis / septic shock, follow existing protocols and local antibiogram.&nbsp;&nbsp;</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Oxygenation</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">If the work of breathing is low, consider a cautious trial of CPAP with oro-nasal mask / NIV with helmet / High flow nasal cannula.&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">If the work of breathing is high or the patient is not tolerating NIV, intubate the patient.&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Always use a </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"><strong>lung protective ventilation strategy</strong></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"> (ARDSnet protocol)</span></span></span></p><ul><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tidal volume 6ml/kg</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">RR 15-35/min</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">PEEP 5-15cm H2O&nbsp;</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Target plateau pressure &lt; 30cm H2O&nbsp;</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Target SpO2 88-95% and/or PaO2 55-80mmHg.</span></span></span></li></ul><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Prone ventilation is considered when there is refractory hypoxemia characterised by:</span></span></span></p><ul><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">PaO2/FiO2 ratio &lt;150&nbsp;</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">FiO2&gt; 0.6&nbsp;</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">PEEP &gt; 5cm H2O</span></span></span></li></ul><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Avoid disconnecting the ventilator circuit, which results in a loss of PEEP. Instead clamp the ET tube first, and then disconnect temporarily if required.&nbsp;</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Anticoagulation</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">High dose prophylactic UFH / LMWH should be given, if not contraindicated.</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">E.g. Enoxaparin 40 mg or 0.5 mg/kg s.c twice a day.&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Contraindications: End stage renal disease, active bleeding, emergency surgery</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Use a validated score to assess bleeding risk (HAS-BLED score). D-Dimer and SIC score can be used for further risk stratification. SIC score &ge; 4 implies a greater risk of bleeding. </span></span></span><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">If the patient is currently taking anti-platelet medication, follow AHA / ESC or ISTH guidelines.</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Corticosteroids</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Steroids are given for 5 - 7 days. Either Methylprednisolone IV or Dexamethasone is used.&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Dosage: </span></span></span><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Methylprednisolone 1 - 2 mg/kg IV&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Dexamethasone 0.2 - 0.4 mg/kg</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Sedation, Nutrition and Sepsis</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Follow existing protocols for sedation and nutrition. </span></span></span><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">For the management of Sepsis / Septic shock use existing protocols, and local antibiogram.</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tocilizumab</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tocilizumab (also known as Atlizumab)&nbsp; is an investigational therapy that is used in moderate to severely ill patients, with increasing oxygen requirements and raised inflammatory biomarkers, despite use of corticosteroids. </span></span></span><br /><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tocilizumab is an immunosuppressive drug.</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Dosage:&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Inj. Tocilizumab 8 mg/kg (max dose: 800 mg, usual dose: 400 mg) given slowly in 100 ml NS over 1 hour.</span></span></span><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">The dose can be repeated after 12 - 24 hours if there is no improvement.&nbsp;</span></span></span></p>",
        "type": "rectangle",
        "parentId": "5"
    },
    {
        "id": "10",
        "name": "Admit to DCH",
        "color": "#74c5d8",
        "border": "#74c5d8",
        "featured_text": "",
        "content": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Severe cases are admitted to the DCH. The treatment protocol includes 3 standard and 1 investigational therapy.</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Standard therapies are:&nbsp;</span></span></span></p><ol><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Oxygenation</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Anticoagulation</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Corticosteroids</span></span></span></li><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Sedation and Nutrition&nbsp;</span></span></span></li></ol><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">New therapies (investigational) include:</span></span></span></p><ol><li style=\"list-style-type:decimal\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tocilizumab</span></span></span></li></ol><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">For the management of sepsis / septic shock, follow existing protocols and local antibiogram.&nbsp;&nbsp;</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Oxygenation</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">If the work of breathing is low, consider a cautious trial of CPAP with oro-nasal mask / NIV with helmet / High flow nasal cannula.&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">If the work of breathing is high or the patient is not tolerating NIV, intubate the patient.&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Always use a </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"><strong>lung protective ventilation strategy</strong></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\"> (ARDSnet protocol)</span></span></span></p><ul><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tidal volume 6ml/kg</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">RR 15-35/min</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">PEEP 5-15cm H2O&nbsp;</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Target plateau pressure &lt; 30cm H2O&nbsp;</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Target SpO2 88-95% and/or PaO2 55-80mmHg.</span></span></span></li></ul><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Prone ventilation is considered when there is refractory hypoxemia characterised by:</span></span></span></p><ul><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">PaO2/FiO2 ratio &lt;150&nbsp;</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">FiO2&gt; 0.6&nbsp;</span></span></span></li><li style=\"list-style-type:disc\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">PEEP &gt; 5cm H2O</span></span></span></li></ul><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Avoid disconnecting the ventilator circuit, which results in a loss of PEEP. Instead clamp the ET tube first, and then disconnect temporarily if required.&nbsp;</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Anticoagulation</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">High dose prophylactic UFH / LMWH should be given, if not contraindicated.</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">E.g. Enoxaparin 40 mg or 0.5 mg/kg s.c twice a day.&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Contraindications: End stage renal disease, active bleeding, emergency surgery</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Use a validated score to assess bleeding risk (HAS-BLED score). D-Dimer and SIC score can be used for further risk stratification. SIC score &ge; 4 implies a greater risk of bleeding. </span></span></span><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">If the patient is currently taking anti-platelet medication, follow AHA / ESC or ISTH guidelines.</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Corticosteroids</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Steroids are given for 5 - 7 days. Either Methylprednisolone IV or Dexamethasone is used.&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Dosage: </span></span></span><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Methylprednisolone 1 - 2 mg/kg IV&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Dexamethasone 0.2 - 0.4 mg/kg</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Sedation, Nutrition and Sepsis</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Follow existing protocols for sedation and nutrition. </span></span></span><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">For the management of Sepsis / Septic shock use existing protocols, and local antibiogram.</span></span></span></p><h2><span style=\"font-size:16pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tocilizumab</span></span></span></h2><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tocilizumab (also known as Atlizumab)&nbsp; is an investigational therapy that is used in moderate to severely ill patients, with increasing oxygen requirements and raised inflammatory biomarkers, despite use of corticosteroids. </span></span></span><br /><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Tocilizumab is an immunosuppressive drug.</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Dosage:&nbsp;</span></span></span></p><p><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">Inj. Tocilizumab 8 mg/kg (max dose: 800 mg, usual dose: 400 mg) given slowly in 100 ml NS over 1 hour.</span></span></span><br /><span style=\"font-size:11pt\"><span style=\"font-family:Arial\"><span style=\"color:#000000\">The dose can be repeated after 12 - 24 hours if there is no improvement.&nbsp;</span></span></span></p>",
        "type": "rectangle",
        "parentId": "5"
    }
])